Takano and colleagues in a protein profiling study of serum samples acquired from 65 endometrial cancer cases and 40 controls reported that serum apolipoprotein A-1 detects endometrial cancer with 75% sensitivity while the combined panel of apolipoproteins A1 and C-1 exhibited a sensitivity of 82%. Here, APOA1 is linked to endometrial cancer.